Skip to main content
. 2023 Nov 27;24(1):2285817. doi: 10.1080/15384047.2023.2285817

Figure 3.

Figure 3.

The function of VASH1 in clinical diagnosis. VASH1 could be used as a beneficial biomarker for clinical diagnosis in CHOL (a), KIRC (b), LIHC (c), LUAD (d), LUSC (e), OV (f), STAD (g), THCA (h) and UCEC (i). CHOL, cholangiocarcinoma; KIRC, renal clear cell carcinoma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OV, ovarian serous cystadenocarcinoma; STAD, stomach adenocarcinoma; THCA, thyroid carcinoma; UCEC, uterine corpus endometrial carcinoma.